Marksans Pharma P/E Ratio
Marksans Pharma (MARKSANS) P/E ratio is 27.07 (High), EPS (TTM) ₹8.40, current price ₹249.27 on NSE vs historical average P/E of 15.12 (85.7th percentile) — High - Growth expectations or overvalued. For live price, revenue and the complete fundamental profile, see Marksans Pharma share price chart.
Current Valuation Metrics
Valuation Signal
Sector Context
Earnings Breakdown (TTM)
MARKSANS P/E Ratio — Valuation Signal & Historical Context
Marksans Pharma P/E 27.07 vs historical average 15.12, range 3.55–38.27 — signal: Overvalued. Browse MARKSANS complete financial statements for revenue, profit, balance sheet and cash flow data.
- Stock appears overvalued with PE of 27.07, suggesting caution for new investments
- Current PE is 79.1% above historical average
- Trading at discount to sector average PE of 49.16
Marksans Pharma P/E Ratio Historical Trend
MARKSANS annual price-to-earnings ratio — 7 years, EPS and year-end price. Current P/E 27.07 vs historical average 15.12. Analyse MARKSANS shareholding pattern to track promoter, FII and institutional holdings.
MARKSANS Historical P/E Ratio — EPS, Year-End Price & Valuation
Marksans Pharma annual P/E ratio, EPS (₹), year-end price and valuation category on NSE.
| Year | P/E Ratio | EPS (₹) | Year-end Price (₹) | Exchange | Valuation |
|---|---|---|---|---|---|
| 2025 | 38.27 | 7.96 | ₹304.65 | NSE | High |
| 2024 | 19.76 | 8.13 | ₹160.65 | NSE | Moderate |
| 2023 | 8.21 | 7.17 | ₹58.85 | NSE | Low |
| 2022 | 11.82 | 5.23 | ₹61.80 | NSE | Low |
| 2021 | 10.6 | 5.75 | ₹60.95 | NSE | Low |
| 2020 | 3.55 | 4.83 | ₹17.15 | NSE | Low |
| 2019 | 13.62 | 2.07 | ₹28.20 | NSE | Low |
MARKSANS vs Healthcare Peers — P/E Ratio Comparison
Marksans Pharma P/E 27.07 vs Healthcare average 49.16, median 29.34 — range 0.97–869.57.
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Welcure Drugs & Pharmace… | WELCURE | 0.97 | ₹36 | Low |
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Phaarmasia | PHRMASI | 3.13 | ₹53 | Low |
| Sun Pharma Advanced Rese… | SPARC | 4.39 | ₹7,561 | Low |
| Ind Swift Laboratories | INDSWFTLAB | 4.61 | ₹1,146 | Low |
| Amwill Health Care | AMWILL | 6.04 | ₹65 | Low |
| Mono Pharmacare | MONOPHARMA | 6.85 | ₹20 | Low |
| Medicamen Organics | MEDIORG | 6.94 | ₹28 | Low |
| Brooks Laboratories | BROOKS | 7.38 | ₹166 | Low |
| Shelter Pharma | SHELTER | 7.4 | ₹54 | Low |